Wexford Capital LP Bristol Myers Squibb CO Transaction History

Wexford Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $1.14 Million - $1.3 Million	17,389 New	17,389 $1.21 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $140,101 - $157,573	-2,361 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $4.54 Million - $5.15 Million	-78,697 Reduced 97.09%	2,361 $146,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $6.26 Million - $6.93 Million	-108,970 Reduced 57.34%	81,058 $4.89 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $6.42 Million - $7.51 Million	117,152 Added 160.76%	190,028 $11.2 Million
Q1 2020 May 18, 2020	BUY	$46.4 - $67.43 $3.38 Million - $4.91 Million	72,876 New	72,876 $4.06 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $6.78 Million - $8.09 Million	-150,315 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $7.33 Million - $9.5 Million	150,315 New	150,315 $7.81 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.